+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Serum glycoproteins in the liver diseases. VII. Further studies on the properties of desialylated glycoprotein binding activity in particulate fraction of human liver homogenate



Serum glycoproteins in the liver diseases. VII. Further studies on the properties of desialylated glycoprotein binding activity in particulate fraction of human liver homogenate



Gastroenterologia Japonica 14(4): 344-348



Binding of desialylated alpha 1-acid glycoprotein by human liver particulate fraction exhibited a dependence on the presence of calcium chloride whereas Cu+, Mn+, Zn+ Fe+ and Co+ inhibited the binding. The other cations such as K+, Na+, Ba+, Mg+ or Pb+ were determined to be non-effective on the binding activity. The pH of the assay for binding was not critical in the range of 6.5 to 9.5. The binding process required the presence of terminal sialic acid on the particulate protein. Fifty nine per cent of binding activity in the original liver paticulate fraction were recovered in acetone powder. Extraction of the acetone powder with a buffer containing EDTA resulted in an increased total binding activity. After extraction with 1--10% Triton X-100, 60% of the activity were still detected in insoluble fraction.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 038978858

Download citation: RISBibTeXText

PMID: 39866

DOI: 10.1007/bf02774231


Related references

Serum glycoproteins in the liver diseases. VI. The presence of desialylated glycoprotein binding activity in particulate fraction of human liver homogenate. Gastroenterologia Japonica 13(6): 507-511, 1978

Serum glycoproteins in the liver diseases. I. Studies on sialic acid-free glycoproteins-improved competitive binding assay of desialylated glycoprotein by rat liver plasma membrane. Gastroenterologia Japonica 11(4): 300-306, 1976

Serum glycoproteins in the liver diseases. VIII. Desialylated glycoproteins in the liver cirrhosis. Gastroenterologia Japonica 14(4): 349-352, 1979

Serum glycoproteins in the liver diseases. III. Desialylated glycoproteins in the acute hepatitis. Gastroenterologia Japonica 12(2): 39-42, 1977

Serum glycoproteins in the liver diseases. V. Desialylated glycoproteins in chronic hepatitis. Gastroenterologia Japonica 13(6): 503-506, 1978

Serum glycoproteins in the liver diseases. IV. Alpha-1 acid glycoprotein level in liver cirrhosis. Gastroenterologia Japonica 12(2): 43-46, 1977

A diagnostic marker of autoimmune chronic active hepatitis: liver plasma membrane antibody in the serum absorbed with particulate fraction of kidney homogenate. Gastroenterologia Japonica 22(3): 303-311, 1987

Serum glycoproteins in inflammation and malignant diseases of female breast. Studies on the neutral glycoprotein fraction. Il Cancro 23(5): 267-271, 1970

Serum glycoproteins in the liver diseases. II. Radioimmunoassay of alpha-1 acid glycoprotein. Gastroenterologia Japonica 11(4): 307-312, 1976

The binding of desialylated glycoproteins by plasma membranes of rat liver. Development of a quantitative inhibition assay. Journal of Biological Chemistry 247(14): 4633-4640, 1972

Carbohydrate-structure-dependent recognition of desialylated serum glycoproteins in the liver and leucocytes. Two complementary systems. Biochemical Journal 227(2): 345-354, 1985

Modification of the catalytic properties of rabbit liver fructose diphosphatase by a particulate fraction from liver. Archives of Biochemistry and Biophysics 146(1): 153-160, 1971

Modification of the catalytic properties of rabbit liver fructose di phosphatase ec 3.1.3.11 by a particulate fraction from liver. Archives of Biochemistry and Biophysics 146(1): 153-160, 1971

Activity determination of enzymes of energy-producing metabolism in human serum and liver punctate in liver diseases; enzyme activity determination in human liver. III. Klinische Wochenschrift 36(6): 280-287, 1958

Inhibition of binding of desialylated thyroxine binding globulin to liver cell membranes by serum from normal and cirrhotic patients. Federation Proceedings 33(5 Part 2): 1348, 1974